Sneha Talankar

  • Pain Management Devices Market Prognosticated to be Worth US$6.28 Bn by 2023 End

    The global pain management devices market features an increasingly competitive landscape marked by rising level of competition among its players. A plethora of players in the market are vying for higher stakes. To this end, they are focusing on unveiling various types of pain management devices with novel technologies in order to reap competitive benefits. Several prominent players have been engaged in expanding their portfolio to consolidate their shares in the global pain management devices market. Rising investments on research and development activities is likely to up the intensity of competition in the pain management devices market in the coming years.

    Some of the top players operating in the global pain management devices market are Bio-Medical Research (BMR) Ltd., Halyard Health, Stryker Corp, Baxter International Inc., and Boston Scientific Corp.

    The global pain management devices market stood US$3.75 billion in 2016 and is projected to touch a valuation of US$6.28 billion by the end of 2023. This represents a CAGR of 7.6% during the forecast period of 2015–2023.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1143

    Among the various types of products, neurostimulation devices held the leading share in 2015 and is likely to hold its sway throughout the assessment period. The prevalence of high-impact chronic pain conditions such as those by musculoskeletal is expected to bolster the uptake in the next few years.

    Of the key regional markets for pain management devices, North America has been consistently garnering substantial shares over past few years. The regional market for pain management device is anticipated to continue holding prominent shares in the near future, as well. The growth is increasingly fueled by rising incidence sports-related injuries that need pain management devices.

    Prevalence of Sports-Related Musculoskeletal Injuries offers Robust Boost

    The rising demand for better management technologies among patient populations world over is a key factor driving the pain management devices market. Globally rising opioid epidemic has offered an attractive impetus to the demand for pain management technologies. Rising elderly populations, especially in developing and developed nations, has contributed to the prevalence of chronic pain. This is a notable trend bolstering the demand for pain management devices. In numerous countries, the rising incidence of sports and recreation-related injuries leading to hospitalization is bolstering the demand for pain management devices. In particular, the demand is increasingly receiving solid boost from the prevalence of sports-related musculoskeletal injuries in developed countries.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1143

    The global pain management devices market is likely to get attractive impetus from several government initiatives and favorable regulatory landscape. In developed nations, reimbursements for spinal cord stimulation devices for patient populations have been fueling the market’s growth in developed countries.

    Demand for Better Pain Management Devices for Neuropathic Pain creates Substantial Prospects

    The advent of novel pain management devices has created new, exciting avenues in the global market. Increasing pace of commercialization of such devices in recent years has catalyzed rapid market’s expansion.

    The global pain management devices market is likely to witness setbacks on account of low level of patient awareness and the high cost of these devices. Moreover, potential side-effects with certain pain management devices have dampened the uptake. The risk of side effects of skin erosion and surgical site infection associated with neurostimulation implants is a case in point.

    Nevertheless, the rising incidence of neuropathic pain world over is making room for several lucrative avenues for medical device manufacturers. They are expanding their pipeline of products. Moreover, the rising awareness about the ill effects of prescription pain killers kindles patients’ interest in technologically-advanced pain management devices.

    The study presented here is based on a report by Transparency Market Research (TMR) titled “Pain Management Devices Market (Product Type – Electrical Stimulation Devices, Radiofrequency Ablation Devices, Analgesic Infusion Pumps, and Neurostimulation Devices; Application – Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, and Musculoskeletal PainTrauma) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015–2023”.

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Lateral Flow Diagnostic Tests Market Represents a Robust CAGR of Nearly 5.7% 2015-2023

    The demand within the global market for lateral flow diagnostic tests has been rising on account of advancements in the field of healthcare diagnostics, finds Transparency Market Research (TMR). The cost-effectiveness of lateral flow tests has led several entities to enter into the business for lateral flow diagnostic tests. The market vendors have identified the need for simpler diagnostic techniques, and have expanded their service portfolio. Hence, the competitive landscape of the global lateral flow diagnostic tests market is expected to become extremely fragmented in the years to come. The vendors in the global lateral flow diagnostic tests are expected to introduce innovative strategies for business growth.

    The leading vendors in the global market for lateral flow diagnostic tests have made ardent efforts to increase their total revenues. These vendors have invested in core research and development in order to build improved lateral flow test systems. The growth graph of the small and medium-sized vendors in the global market for lateral flow diagnostic tests has been rising at a steady rate. These vendors are projected to form collective alliances in order to fetch the benefits of mutual growth. Some of the key vendors in the global lateral flow diagnostic tests market are Alere, Inc., Bio-Rad Laboratories, Beckman Coulter, Inc., Becton, bioMérieux SA, Dickinson and Company, and EMD Millipore.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7739

    Transparency Market Research (TMR) finds that the global lateral flow diagnostic tests market would expand at a robust CAGR of 5.7% over the period between 2015 and 2023. Furthermore, the global market for lateral flow diagnostic tests held a total value of US$2.30 bn in 2015, and this figure is expected to reach a value of US$3.22 bn by 2023-end. On the basis of geography, the market for global lateral flow diagnostic tests in North America shall expand at a starry rate in the years to come.

    Rising Incidence of Chronic Diseases to Propel Demand

    The demand within the global market for global lateral flow diagnostic tests shall rise on account of the growing incidence of chronic diseases. Some of the common chronic diseases include diabetes, cardiovascular disorders, and cancer. The medical fraternity has shown an inclination towards improved diagnostic facilities which has further given an impetus to market growth. Moreover, the ease of deploying lateral flow diagnostic tests has also played a major role in the growth of the global market. There are no invasive procedures involved in lateral flow diagnostic tests which has in turn generated voluminous revenues in the market.

    Request Brochure of Report: http://nsparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7739

    Cases of Drug Abuse to Propel Demand

    The use of global lateral flow diagnostic tests across rehabilitation centers has gathered momentum. Testing the effect of drugs on the body is done with the help of global lateral flow diagnostic tests. Hence, the global market for lateral flow diagnostic tests has been expanding at a stellar rate in recent times. Moreover, the voluminous investments made by global research organisations towards improved healthcare have also played a key role in market growth. Moreover, the rising incidence of sexually transmitted diseases has also given an impetus to market growth.

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Medical Cameras and Microscopes Market is Forecast to Reach US$1.3 bn by 2023

    The competitive landscape of the medical cameras and microscopes market is oligopolistic with a handful of players operating across the globe, says Transparency Market Research (TMR). Players such as Carl Zeiss Meditec, Olympus Corporation, Nikon Corporation, and Leica Microsystems accounted for a massive 90% of the overall market in 2014.  Top players in the market are adopting several strategies such as merger & acquisitions, business expansions and collaborations to increase their geographical reach..

    According to TMR, the global medical cameras and microscopes market is expected to reach a valuation of  US$1.3 bn by 2023. The market is projected to rise at an impressive CAGR from 2015 to 2023.

    On the basis of type, surgical microscope cameras is expected to hold maximum share in the medical cameras and microscopes market. This is due to their extensive application in research and development centers, hospitals units and specialty clinics. On the basis of geography, North America is expected to hold a majority of share in the medical camera and microscopes market throughout the forecast period. Several factors such as growing prevalence of cancer, rising geriatric population and presence of key players are expected to drive the medical cameras and microscopes market in the region.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1619

    Growing Adoption of Invasive Surgeries to Fuel Market

    The global medical cameras and microscopes market is likely to grow at a significant pace. This is mainly because of the factors like increasing investments in research and development of advanced and sophisticated medical equipment. Medical cameras are mainly used in hospitals, diagnostic centers, and physicians office to investigate closely tiny and inner organs of the body. Medical microscopes are used for inspecting blood and tissue samples. They are widely used in the pathological and surgical applications.

    The increasing inclination of patients towards invasive surgeries is a strong factor likely to boost the global medical cameras and microscopes market during the forecast period. Apart from this,  surge in the use of medical camera and microscopes for surgeries such as neurosurgeries, ophthalmology is another factor anticipated to drive the global medical cameras and microscopes market.

    Along with this, advancement in medical devices  is increasing the demand of the medical cameras and microscopes in the market. For instance- Olympus Corporation launched ORBEYE Surgical Microscope. The device is based on 4K 3D video technology. Olympus Corporation and Sony Imaging Products & Solutions Inc have developed this technology.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1619

    Excessive Tax imposed on Purchase of Medical Cameras and Microscopes to Impede Market

    Nevertheless, growth of the medical cameras and microscopes market is hampered in the regions having a poor medical infrastructure. This is because medical cameras and microscopes are expensive equipment and it requires substantial investment for their setup in healthcare units. Apart from this, implementation of excise tax on medical cameras and microscopes by the government is prohibiting small and middle players from adoption of these devices.

    However, growing prevalence of the chronic diseases such as cancer and blood disorder is likely to offer lucrative avenue for the growth of the medical cameras and microscopes market during the forecast period.

    This review is based on the findings of a TMR report titled “Medical Cameras and Microscopes Market (Type – Endoscopy Cameras, Dermatology Cameras, Ophthalmology Cameras, Dental Cameras, Surgical Microscope Cameras (Ophthalmology, ENT, Neurosurgery) Pathology Microscope Cameras (Hospital Laboratories, Diagnostic Laboratories, Physician Offices)); Type – (Surgical Microscopes, Ophthalmology, ENT, Neurosurgery) Pathology Microscopes (Hospital Laboratories, Diagnostic Laboratories, Physician Offices) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015-2023.”

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • G-protein Coupled Receptors (GPCRs) Market will Exhibit a CAGR of 8.8% From 2014 to 2022

    The leading companies operating in the global g-protein coupled  receptors market are HD Biosciences Co. LTd., Abcam Plc., Promega Corporation, QIAGEN N.V., Sigma-Aldrich Corporation, DiscoveRx Corporation, Enzo Life Sciences, Inc., Cisbio Bioassays, PerkinElmer, Inc., Dickinson and Company, Becton, EMD Millipore, and Thermo Fisher Scientific, Inc., states Transparency Market Research (TMR) in a research report. Most of these market players are incessantly focusing on developing innovative and advanced technologies for improved assays and assay systems of g-protein coupled receptors for maintaining their position in the global market for G-protein coupled receptors market in the long run.

    For instance, GeneBLAzer Validated Functional Assays and Tango GPCR of Thermo Fisher Scientific, Inc., Dickinson and Company, ACTOne cAMPAssay of Becton, and Cyclic AMP assay kits which are cell-based from Cisbio Bioassays that would also aid in capitalizing on the customer preferences in the future. These market vendors are also collaborating with other companies in the global and regional level through long-term ventures and agreements for developing innovative and technologically advanced G-protein coupled receptors assays, assay systems, and platforms.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=550

    According to a TMR analyst, “The global market for G-protein coupled receptors is expected to rise at a CAGR of 8.8% from 2014 to 2022. The market was worth US$1.63 bn in 2013 and is expected to rise to a valuation of US$3.53 bn by the end of 2022.” In terms of therapeutic areas, the market is anticipated to be led by oncology in the years ahead owing to the rising number of cases of cancer. Region-wise, the market is most probably to be led by North America closely led by Europe due to the rise in the case of obesity in these regions.

    Lifestyle Disorders to Influence Market in a Positive Manner

    Expanding commonness of unending way of life issue, for instance, breast cancer, cardiovascular infections, and respiratory issue is prompting higher interest for novel and better treatment choices. G-protein coupled receptors (GPCRs) are exceptionally helpful in the innovative work of newer medication substances. Additionally, the expanding government funding in research and developments activities, for instance, biosensors, orphan drug receptors, sedate targets, and high-throughput screening systems is likewise anticipated to drive the market development.

    Besides, functional and structural literatures on the pharmacological components of the GPCRs are demonstrating that these GPCRs targets have adaptable utilities in the treatment of an expansive range of maladies. Progressing improvements in the scope of therapeutics for treatment of neurobiological, irritation, torment, and different issue are relied upon to help the market development sooner rather than later. Besides, rising use of G-protein coupled receptors in medicate disclosure and advancement forms are required to fuel the market development.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=550

    Cellular Mechanism Understanding to Aid in Adoption Increase

    The GPCRs market is developing relentlessly at a robust rate due their rising interest in sedate disclosure and ADME toxicology examinations, expanded government activities for the advancement of as good as ever medications, and high predominance of endless ailments, for instance, cardiovascular sicknesses, respiratory scatters, and bosom disease. With enhanced comprehension of cell components and presentation of cutting edge instrumentation and test stages, label-free biosensor-based cell measure advancements are relied upon to end up noticeably a dynamic zone for GPCR screening. Rising premium and expanding business investments in GPCRs in regions, for instance, tranquilize targets, high-throughput screening, vagrant receptors and biosensors would additionally add to higher consideration on the assay development market.

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Acute Care Needleless Connectors Market Rising at a CAGR of 10.20%

    With a large pool of vendors of acute care needleless connectors across the world, the global acute care needleless connectors market are displaying a highly competitive business landscape, states a new study by Transparency Market Research (TMR). As researchers review the performance of each of the leading market players in this report, they find out that innovation is pivotal to success in this market and companies are constantly investing in research initiatives to design and develop innovative connectors that meet the dynamic expectations of customers. CareFusion Corp., Becton, Dickinson and Co., Baxter Healthcare Corp., RyMed Technologies, Vygon SA, B. Braun Medical Inc., ICU Medical, and Nexus Medical LLC are some of the leading vendors of acute care needleless connectors, worldwide, reports the study.

    As per TMR estimations, the global market for acute care needleless connectors, rising at a CAGR of 10.20% during the period from 2014 to 2012, is anticipated to reach a value of US$972.0 mn by the end of the forecast period. Hitherto, the demand for complex needleless connectors was higher than products. However, simple needleless connectors are expected to report a rise in their demand at a faster rate in the years to come. Geographically, North America, which is the current leader of the overall market, is projected to continue on the top over the period of the forecast, thanks to the presence of an advanced medical and healthcare infrastructure, notes the research study.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4230

    Increasing Cases of Needlestick Injuries Boosts Demand

    According to the author of the study, “the global market for acute care needleless connectors is witnessing an incredible rise, thanks to the increasing cases of needlestick injuries and blood drawback, together with an escalating base of the geriatric population.” The increasing number of patients suffering from various chronic disorders, such as diabetes, cardiac diseases, and cancer, is also influencing the sales of acute care needleless connectors, as the awareness regarding the benefits of needleless connectors is increasing substantially among medical professionals and patients, both.

    The market is also gaining from the increasing disposable income of people in emerging economies, which has enabled them to spend comfortably on expensive treatments and afford costly medication and medical devices, states the research report.

    High Cost of Branded Acute Care Needleless Connectors to Limit Market’s Growth

    The worldwide market for acute care needleless connectors, although, looks flourishing, it may hit some roadblocks in future, such as the high cost of branded needleless connectors, resulting in consumers reaching for easily available substitutes. The market may also get hampered by the increasing incidence of bloodstream infections triggered by catheters.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4230

    Nonetheless, the market will still prosper in the years to come, thanks to the rising investments made by emerging economies in research and development initiatives. With companies increasingly establishing their production units in emerging countries, the market is likely to witness a high growth in the coming years, reports the market study.

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Small Animal Imaging Market to Rise with a Strong CAGR of 8.6% BY 2020

    The vendor landscape of the global market for small animal imaging features an intense level of competition due to the presence of numerous well-established players, according to a recent market research report by Transparency Market Research. The rising set of growth opportunities in the field of veterinary medicine has compelled companies to focus on bringing innovations in the field of production. Companies are also focused on R&D activities so as to develop technologically more advanced imaging technologies to gain a larger hold on the market.

    For improved sales, companies could plough more resources into MRI-based multimodal imaging devices such as PET or MRI as the demand for such devices has been rising at a promising pace in the past few years. Bruker Corporation, Agilent Technologies, Inc., TriFoil Imaging, Inc., LI-COR Biosciences, Inc., Aspect Imaging, and Miltenyi Biotec GmbH are some of the leading companies in the market.\

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2469

    According to the report, the global market for small animal imaging will exhibit an impressive 8.6% CAGR over the period between 2014 and 2020, rising to a revenue valuation of US$ US$2.7 bn by 2020. Geographically, the markets in regions such as Asia Pacific, Middle East and Africa, and Latin America are expected to present the most lucrative set of growth opportunities over the report’s forecast period. The rising numbers of pharmaceutical and biopharmaceutical preclinical researches in these regions will contribute to the promising set of growth opportunities.

    Rise in Numbers of Gene Expression Studies to Boost Market

    One of the key factors expected to drive the market is the vast rise in investment in the development of new diagnostic and therapeutic measures aimed at the various ailments in small animals. The market is also expected to benefit majorly from the rising focus on research activities aimed at further understanding regarding gene expression and its link with a number of diseases in small animals. The market has also significantly benefitted from the rising installation of optical and multimodal imaging devices across specialty veterinary clinics across the globe.

    The rising numbers of contract research organizations in Asia Pacific and a promising rise in research activities aimed at the treatment and diagnosis of diseases in small animals has also resulted in a promising rise in demand for small animal imaging devices globally. Similar trend is also likely to prevail in other regional markets with emerging economies.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2469

    High Cost Involved in Manufacturing Could Hamper Market Growth

    Despite mostly promising growth opportunities, the market could be restrained to a certain degree in the next few years. One of the toughest challenges faced by the market is the high cost involved in the manufacturing of imaging devices for small animals. Owing to this factor, the market fails to target a potentially vast set of growth opportunities in emerging economies, where the consumer is cost-conscious and could prefer other diagnostic and treatment measures due to the cost factor.

    This analysis of the global small animal imaging market is based on a recent market research report by Transparency Market Research, titled “Small Animal Imaging Market (Devices – Micro-CT Imaging, Micro-MRI Imaging, Micro-PET/SPECT Imaging, Multimodal Imaging, Optical Imaging, Micro-ultrasound Imaging, and Micro-PAT; Reagents – Computed Tomography (CT) Contrast Reagents, MRI Contrast Reagents, Nuclear Imaging Contrast Reagents, Optical Imaging Contrast Reagents, and Ultrasound Contrast Reagents; Application – Oncology, Cardiology, Autoimmune Diseases, and Neurology and Psychiatry) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014–2020.”

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market will Exhibit a CAGR of 23.70% by 2020

    A new report on the global NDDS in cancer therapy market has been published by Transparency Market Research. The research, titled ‘Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,’ studies the regional markets, key growth drivers, technology segmentation, current trends, and competitive landscape. The analysts predict that the global market will progress from US$3.6 bn in 2013 to US$15.9 bn by 2020.

    Novel drug delivery systems (NDDS) in cancer therapy comprises technologies such as liquid embolics, nanoparticles, and embolization devices that offer unique ways to cure cancer. In recent years, there has been increasing incidence of various types of cancer across the globe. Technological advances have led to the growth of new therapies. There have also been many developments in drug delivery systems due to the increasing government funding. All these factors have led to the growth of the global novel drug delivery systems (NDDS) in cancer therapy market.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3590

    According to the publication, the global NDDS in cancer therapy market is expected to exhibit a whopping 23.70% CAGR from 2014 to 2020. However, strict government regulations and the high cost of new products can hamper the growth of the global market.

    The report’s authors have segmented the global NDDS in cancer therapy market on the basis of technology and region. Based on technology, the global NDDS in cancer therapy market is classified into embolization particles, liquid embolics, and nanoparticles. In 2013, the nanoparticles drug delivery systems segment stood at US$3,307.7 mn and is projected to exhibit a 24.70% CAGR from 2014 to 2020. Nanoparticles such as Megace ES (megestrol acetate) Abraxane (paclitaxel) DepoCyt (liposomal cytarabine), DaunoXome (daunorubicin citrate), Myocet (doxorubicin), and Doxil (doxorubicin) are approved as novel drug delivery systems in cancer therapy. The liquid embolics segment is predicted to record a steady 4.90% CAGR from 2014 to 2020.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3590

    Based on region, the global NDDS in cancer therapy market is divided into Europe, Asia Pacific, North America, and Rest of the World. In 2013, North America accounted for a massive 46.6% of the global NDDS in cancer therapy market. The increasing number of cancer patients, advanced healthcare infrastructure, and favorable reimbursement policies are the factors that can be held responsible for the growth of the North America NDDS in cancer therapy market. In 2013, Europe held a share of 29.2% in the global NDDS in cancer therapy market. Technical advancements in the development of innovative products and the increasing number of pipeline products are projected to benefit the Europe NDDS in cancer therapy market. The Asia Pacific NDDS in cancer therapy market is projected to expand at a 22.60% CAGR from 2014 to 2020, propelled by the development of economies such as India, China, Japan, and Australia.

    Advanced Medical Isotope Corporation, Eckert & Ziegler BEBIG, Bind Therapeutics, Polysciences, Inc., Nanobiotix, CeloNova BioSciences, Inc., Covidien, plc, EmboMedics, Inc., Cook Medical, Inc., and Mo-Sci Corporation are some of the prominent companies operating in the global NDDS in cancer therapy market.

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Intrathecal Pumps Market is Likely to be Worth US$0.26 Bn by 2020

    The global intrathecal pumps market is foretold to see its growth propelled on the back of partnerships, mergers and acquisitions, and other market consolidation activities. Players are expected to focus on the launch of new products with increased device longevity, accurate drug delivery, and innovative technology. A report by Transparency Market Research (TMR) sheds light on the nature of the competitive landscape and profiles some of the leading market players such as Flowonix, Inc., Medallion Therapeutics, Inc., Arrow International, Inc., Medtronic, Inc., and Codman & Shurtleff, Inc. New players introducing self-care medical devices at affordable prices could enter the market in the near term.

    TMR envisages the global intrathecal pumps market to reach a valuation of US$0.26 bn by the completion of 2020. In terms of application, pain management could take a commanding position in the market. By region, North America is foreseen to lead the market with its larger share.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1599

    Intrathecal Pumps Win Preference in Long-term Treatment, Gathering High Demand

    Adoption of intrathecal pumps is envisioned to improve with technological advancement witnessed in the global market. Developments in technology have paved the way for the introduction of advanced products with sophisticated features. Demand for intrathecal infusion pumps could increase while riding on expanding base of patients with cancer and other chronic diseases. Long-term treatments requiring drugs to be infused for an extended period of time could increase the demand in the world intrathecal pumps market. Players are expected to testify a dramatic expansion of the market due to rise in demand for more advanced infusion systems with swelling prevalence of chronic diseases.

    Approximately, 20-30% of the U.S. population is affected by chronic diseases, mentions the TMR report. In this regard, it could be said that North America may win a higher market share followed by that of Europe. On the other hand, emerging regions such as Asia Pacific are projected to create rewarding prospects in the market, especially in China and India.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1599

    Demand at Mercy of System Modifications to Ensure Accurate Drug Administration

    Technological advancement has given a much needed boost to the international intrathecal pumps market in terms of growth. However, stability issues could create a drawback in the market since multiple medications may be required to administer in varying concentrations and precise dosages. This raises the need for more improvements on the part of intrathecal pumps for accurately administering drugs with no or at least negligible errors. Furthermore, medical complications and risks associated with the use of intrathecal pumps could discourage the market from achieving its true potential.

    However, unmet medical needs despite the availability of oral therapies are predicted to give rise to lucrative prospects in the international intrathecal pumps market. Moreover, increase in awareness about the need for technological advancement and proper diagnosis for effective treatment of chronic diseases could improve demand for intrathecal pumps during the course of the forecast period.

    The information presented in this review is based on a TMR report, titled “Intrathecal Pumps Market (Application – Pain Management and Spasticity Management) – Global Industry Analysis, Size, Share, Procedures, Growth, Trends and Forecast, 2014 – 2020.”

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Drug Reconstitution at the Point-of-Care Market Value Projected to Expand by 2019

    Today, a majority of newly approved drugs are being marketed in lyophilized form for reconstitution at the point of care as molecular complexity of these drugs does not allow their distribution in a liquid form. Earlier, reconstitution and mixing was quite difficult and used to involve multiple steps that’s why drugs requiring reconstitution were used to administer in healthcare settings by medical professionals resulting into higher treatment costs. Continued development in healthcare has led to the inception of advanced technologies leading to reconstitution of the drugs by patients themselves requiring treatment for a variety of diseases such as multiple sclerosis, hemophilia and rheumatoid arthritis.
    A variety of medical devices used for reconstituting drug before administration are dual chamber syringes, dual chamber cartridges, direct connect to vial, vial adapters, vial to vial systems, closed system transfer device and needle less transfer devices. Some of the commercially available medical devices for drug reconstitution at the point of care are EZMix and Unifill Select marketed by an American company Unilife. Some of the key players operating in this market are Unilife, Sensile medical, Integrity Bio, Eli Lilly, Becton Dickinson, Alkermes, Bioject Medical technologies, Inc., Baxa Ltd. and Bespak Europe Ltd.
    The global market for drug reconstitution at the point of care is driven by increasing demand of drugs requiring reconstitution, increasing pharmacological efficacy and advancements in technology leading to easy drug reconstitution such as Dual chambers in a single device has enabled the storage of drug powder and diluents separately without any interaction. SenseLyo, a drug reconstitution system marketed by Sensile Medical enables automated filling of various drug reservoir types and sizes.
    Growing number of new chemical entities being used as therapeutic agents also increases the demand for drug reconstitution devices rendering them stability at room temperature. Geographically, North America represents the largest market as biologic drugs are in great demand in these regions that requires drug reconstitution prior administration. Emerging countries are expected to show substantial growth in coming future along with the growing demand for biologics and increasing incidences of chronic diseases such as diabetes, cardiovascular and autoimmune diseases.
    This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
    • North America
    • Asia Pacific
    • Europe
    • Rest of the World
    This report provides comprehensive analysis of 
    • Market growth drivers
    • Factors limiting market growth
    • Current market trends
    • Market structure
    • Market projections for upcoming years

    Request For TOC : https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1612

    This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Gastrointestinal Endoscopic Devices Market Poised to Garner Maximum Revenues by 2019

    Devices used to inspect the internal lining of the gastrointestinal tract are termed as gastrointestinal endoscopic devices. Gastrointestinal (GI) tract includes small intestine, large intestine, duodenum, colon, stomach, cecum and rectum. Any infection or abnormalities in function of this GI tract is detected for using gastrointestinal endoscopic devices. These devices are helpful in detecting the cause of abdominal bleeding, vomiting, persistent pain, inflammation and tumor affecting the esophagus, duodenum and stomach. In addition they also help in treating these GI diseases. Various GI diseases include ulcer, gastroesophageal reflux disease, hemorrhoids, colon cancer, diverticulitis, bowel syndrome and Crohn’s disease.

    Read Report Overview: https://www.transparencymarketresearch.com/gastrointestinal-endoscopic-devices.html

    Gastrointestinal endoscopic devices include thin flexible tube, light attached to thin flexible tube and a visualizer. Other components of this device are viewing sheath, power source, rheostat, lasers, insufflators, battery box, bulbs, fiberoptic lighting, hand instruments, electrosurgical and radiofrequency instruments. The process of detecting GI tract abnormalities through GI endoscopic devices is termed as gastrointestinal endoscopy. This process starts with anesthetizing the patient and then putting thin wire in the GI tract through mouth. The internal structure image is displayed on the visualizer. This image helps the physician to detect and treat the GI infections.

    Gastrointestinal endoscopic devices are further segmented as endoscopic retrograde cholangiopancreatography devices (ERCP), hemostatis devices, capsule endoscopy, biopsy devices and GI videoscopes. GI videoscopes include video gastroscopes, video duodenoscopes, video colonoscopies, video ultrasound endoscopes, video enteroscope and video sigmoidoscope. Other GI endoscopic devices include stents, enteral feeding devices, esophageal dilation balloons, polypectomy snares, and anti-reflux devices.

    Request Brochure of Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1406

    Changing lifestyle has changed the diet pattern. The new diet has reduced the intake of various healthy foods which increases the incidence of digestive tract problems. In addition, increase in GI diseases has also triggered the growth of this market. Recently in year 2011, 1 million of the total worldwide population has been detected with colon and rectum cancer. Weight management treatment has also contributed in its growth since this therapy includes gastric banding and bypass surgery. Global increase in disposable income has also boosted the growth of this market. Despite all the advantages, the growth of this market would be hampered due to lack of sufficient reimbursement policies and reduced government funding in various nations such as Europe and U.S. respectively. In addition, high costs and delayed approval process would also hinder the growth of this market.

    Some of the major market players in this industry are Covidien Ltd., Boston Scientific Corporation, Conmed Corporation, Johnson & Johnson Ltd., Fujinon Ltd., Stryker Corporation and other significant players.

    Request For TOC : https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1406

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Vitamin Tonics Market to Witness Widespread Expansion by 2023

    Global Vitamin Tonics Market: Overview

    Vitamins are among the most vital supplement classes consumed by people. They complete a range of core physical and mental capacities in the body. Lack of vitamins can prompt serious conditions, such as rickets (vitamin D insufficiency), scurvy (vitamin C inadequacy), and pellagra (vitamin B). Along these lines, general utilization of vitamins is viewed as an extremely healthy practice.

    Read Report Overview: https://www.transparencymarketresearch.com/vitamin-tonics-market.html

    In spite of the fact that individuals in developing regions still consistently fall prey to them, vitamin deficiency ailments are basically inconceivable in the modern era. All things considered, the hectic ways of life of current consumers don’t enable them to routinely devour a sound eating habit. Accordingly, vitamin supplements have turned out to be progressively famous around the globe. Vitamin tonics comprise of different types of vitamin supplements and are utilized by individuals everywhere throughout the world to top up their dietary vitamin consumption.

    The expanding wellbeing awareness among the worldwide populace is the essential driver of the worldwide vitamin tonics market. As urbanization soars across the globe, an expanding pool of the worldwide populace thinks that it’s hard to invest enough energy to cook an intricate supper. This can bring about a few dietary issues, since the healthful necessities are frequently not met. Vitamin tonics are of enormous help to such people, in this manner driving the demand in the worldwide market.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11168

    Global Vitamin Tonics Market

    Vitamins are among the most important nutrient classes consumed by humans. They carry out several vital physical as well as mental functions in the body. Deficiency of vitamins can lead to severe conditions such as scurvy (vitamin C deficiency), rickets (vitamin D deficiency), and pellagra (vitamin B deficiency). Thus, regular consumption of vitamins is considered a healthy habit.

    Though people in less developed regions still regularly fall prey to them, vitamin deficiency disorders are virtually unheard of in the modern world. Even so, the hectic lifestyles of modern consumers don’t allow them to regularly consume a healthy diet. As a result, vitamin supplements have become increasingly popular around the world. Vitamin tonics consist of various forms of vitamin supplements and are used by people all over the world to top up their dietary vitamin intake.

    The report examines every aspect of the global vitamin tonics market and presents the competitive and commercial dynamics of the market. Reliable analysis tools such as SWOT analysis and Porter’s five forces analysis have been used to arrive at detailed conclusions about every aspect of the global vitamin tonics market. The drivers and restraints and key segments of the vitamin tonics market, as well as the major companies operating in it, have been profiled in the report.

    Request For TOC : https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=11168

    Global Vitamin Tonics Market: Drivers and Restraints

    The increasing health consciousness among the global population is the primary driver of the global vitamin tonics market. As urbanization carries on at peak rates around the world, an increasing pool of the global population finds it difficult to spend enough time to cook an elaborate meal. This can result in several dietary disorders, since the nutritional requirements are often not met. Vitamin tonics are of immense help to such individuals, thus driving the demand in the global market. This also ties in with the general trend of rising preference for preventive medicine over curative, with vitamin tonics helping consumers avoid several possible diseases due to the varied functions performed by vitamins.

    Despite the risk of overconsumption of vitamins, vitamin tonics are usually available to the general public without prescriptions, since they are classified as a dietary supplement. This has significantly driven the global vitamin tonics market, since the products can be purchased easily. The increasing sale of nutritional supplements on online portals has also been a major factor propelling the global vitamin tonics market.

    Companies operating in the global vitamin tonics market have capitalized on the rising awareness among the global population by conducting several awareness programs about vitamin tonics. This has further boosted the prospects of the global vitamin tonics market.

    Global Vitamin Tonics Market: Regional Overview

    Regionally, North America is the largest market for vitamin tonics. The large demand for vitamin tonics in the region is due to the high rate of urbanization in countries such as the U.S., as well as the high medical awareness among the general population. However, the dominant share of North America is being slowly eroded by emerging regions such as Asia Pacific and Latin America. The increasing urbanization in these regions is giving rise to conditions due to which the vitamin tonics market has flourished in North America. This has also prompted several major players in the global vitamin tonics market to shift their focus toward Asia Pacific.

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Tissue Engineering and Organ Regeneration Market to Develop Rapidly by 2019

    The tissue engineering and organ regeneration market is a vital part of the field of medicine. Tissue engineering and organ regeneration is primarily used for treating burns and accident wounds, for cosmetic surgeries, in correcting birth defects, wound care, orthopedics, and in neurology, amongst others. The recent development in the engineering cell growth segment has encouraged the healthcare field to adopt it thanks to the increased knowledge bank about the procedure and the principle behind it.

    Read Report Overview: https://www.transparencymarketresearch.com/tissue-engineering-organ-regeneration.html

    Advancements in cell culture technology, stem cell technology, and immunopassivation and immunomodulation have widened the reach of market players as it is creating a whole new knowledge base for treating various conditions. Application in cardiovascular surgeries is also likely to create a sustainable opportunity for this market.

    Overview of the Global Tissue Engineering and Organ Regeneration Market

    In recent years, the tissue engineering market has witnessed a rapid diversification and growth as it allows circumvention of the problem of organ shortage. This market has seen incredible developments such as advancements in technologies, biomaterials, biochemistry, molecular medicine, genetics, nano technology, and biomedical engineering. All of these have helped the global tissue engineering and organ regeneration market to repair or to regenerate human organs either through cell expansion or regeneration.

    Growing incidences of birth defects, burns, accidents, and such other mishaps account for 10 million cosmetic or reconstructive procedures across the globe. This has led to impressive growth of the global tissue engineering and organ regeneration market, which is eating into the market for metals and alloys that are used in body implants, as they have a toxic effect leading to poisoning in worst-case scenarios and come with a very high rate of rejection.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1998

    The biggest market share in the global tissue engineering and organ regeneration market is held by procedures for the liver, kidney, and heart transplants, as they not only cost less when processed from the same individual, but also reduce the risk of rejection and increase the success rate of the surgical procedures. Other major contributors to the global tissue engineering and organ regeneration market are orthopedics and wound care segments.

    According to research analysts, growing applications of tissue engineering and organ regeneration in neurological and dental segments are also likely to add to the growth of this market in the near future. The exorbitant cost of organ transplantation, painstaking waiting periods, and increasing adoption of 3D printing in tissue and organ regeneration will also be significant growth drivers for the global tissue engineering and organ regeneration market.

    Request For TOC : https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1998

    Players in the Global Tissue Engineering and Organ Regeneration Market

    The report also profiles some of the key players in the global tissue engineering and organ regeneration market, such as CryoLife, Integra LifeSciences, Genzyme/Sanofi, LifeCell/ Kinetic Concepts, BioMemetic Therapeutics, Cook Biotech, StemCellsInc, Osiris Therapeutics, Tengion, NuVasive, Cytori Therapeutics, and AastromBioSciences.

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Benign Prostatic Hyperplasia (BPH) Therapeutics Market to be at Forefront by 2019

    Benign prostatic hyperplasia (BPH) or benign prostatic hypertrophy, is a urological disorder that involves proliferation of the cellular components of the prostrate. BPH is the most common form of neoplasm in men. BPH results in the formation of large nodes and nodules in the periurethral region of the prostate. The significantly large nodules compresses the urethral canal that causes to partial or complete urinary tract obstruction which inhibits the normal flow of urine. Obstruction in the urinary tract further leads to complications such as urinary retention, urinary tract infections and urinary hesitancy.
    Some of the medical therapies used for the treatment of BPH are as follows:
    • Alpha-Blockers
    • 5- Alpha-reductase inhibitors (5-ARIs)
    • Alpha-Adrenergic Blockers
    • Phosphodiesterase-5 Enzyme Inhibitors
    • Anticholinergic Agents
    • Nonselective alpha-blockers
    Some of the surgical interventions used of the treatment of BPH are as follows:
    • Holmium Laser Resection of the Prostate (HoLRP)
    • Open prostatectomy
    • Photoselective vaporization of the prostate (PVP)
    • Transurethral holmium laser ablation of the prostate (HoLAP)
    • Transurethral resection of the prostate (TURP)
    • Transurethral vaporization of the prostate (TUVP)
    • Transurethral incision of the prostate (TUIP)

    Request Brochure of Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1872

    Geographically, North America is the leading market due to high prevalence rate of benign prostatic hyperplasia and lower urinary tract symptoms (LUTS). Various studies reports that 90% of men in the U.S., aged between 45 and 80 years suffer from some type of LUTS and approximately 14 million men in the U.S. have symptoms of BPH. Asia-Pacific is also expected to witness a significant growth due to the rise in various urological disorders and complications. However, BPH tends to be more progressive in African-American men owing to the presence of high testosterone level in their body.
    Rise in geriatric population is expected to be one of the major driver that might drive the market. Additionally, increased awareness for prostate cancer and other urological disorders, are also expected to fuel the growth of the global BPH therapeutics market. However, high adoption rate of minimally invasive surgeries such as transurethral microwave thermotherapy (TUMT), laparoscopic prostatectomy and transurethral needle ablation (TUNA) might impede the growth of the BPH therapeutics market.
    Some of the key players in the benign prostatic hyperplasia (BPH) therapeutics Market are AEternaZentaris Inc., Astellas Pharma Inc., Eli Lilly and Company, EndoCeutics, Inc., IntelGenx Technologies Corp., Ipsen S.A., Nymox Pharmaceutical Corporation, Protox Therapeutics Inc. and Quest PharmaTech Inc.

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Oral Care Products Market to Register a Stout Growth by End 2024

    Global Oral Care Products Market: Overview

    Oral care domain includes a wide range of treatment and products that are designed to enhance oral hygiene and deliver dental care. The rising awareness regarding oral hygiene is causing a shift from traditional products to innovative appliances, formulations, and implements. The increasing consciousness regarding maintaining an aesthetically pleasing smile, oral health, and fresh breath, particularly among consumers in urban areas, is stimulating the growth of the global oral care products market. Over the past few years, the market has witnessed tremendous technological breakthroughs, which have resulted in the launch of innovative and high-performance products. The trend is likely to continue in the near future as well.

    Read Report Overview: https://www.transparencymarketresearch.com/oral-care-products-market.html

    The research report is an in-depth analysis of the various critical parameters of the global oral care products market. These parameters include market dynamics, product type, geographical segmentation, and competitive landscape. The report profiles prominent players in the market along with their market shares, revenue generation, latest developments, business strategies, and contact information. It performs a SWOT analysis that reveals the potential growth trajectory of each key player in the market.

    Global Oral Care Products Market: Drivers and Restraints

    The increasing consumer spending power is translating into the greater uptake of advanced oral care products. The rapidly growing geriatric population is also leading to the higher demand for oral care products as aged people are more susceptible to dental problems. Moreover, the rising prevalence of caries and periodontal diseases is fuelling the market. Furthermore, the growing dental tourism and increasing demand for cosmetic dentistry are augmenting the market.

    On the other hand, the high cost of oral care products is limiting their widespread adoption. This is further compounded by the lack of reimbursement policies for dental care in several countries. However, consumers in emerging countries are trading up to products such as automated toothbrushes and vibrators, which in turn is unfolding significant growth opportunities for the market.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=267

    Global Oral Care Products Market: Geographical Segmentation

    The key regional markets meticulously examined in the report are Europe, Asia Pacific, North America, and Rest of the World. North America and Europe, collectively, account for a large share in the market. The growth of these regions is fuelled by the growing geriatric population and increasing demand for advanced dental procedures. Rising government expenditure on oral healthcare is also backing the growth of these regions. In Europe, the presence of favorable reimbursement policies, the booming trend of premiumisation, and the high penetration rate of dental implants are providing a fillip to the market.

    Asia Pacific is expected to register a noteworthy CAGR during the forecast period. The rising prevalence of dental diseases, continuous technological advancements, and growing medical tourism in countries such as China, India, and South Korea are contributing to the growth of the region. The market in the region is also benefitting from the increasing disposable incomes, which is resulting in increased expenditure on oral healthcare.

    Request For TOC : https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=267

    Global Oral Care Products Market: Competitive Landscape

    With the increasing consumer scrutiny for credibility and function, players in the global oral care products market are focusing towards new and innovative product development. The majority of players are putting notable efforts in expanding their product portfolio, which in turn is also exposing them to high pricing pressure. Some of the key players operating in the global oral care products market are Colgate–Palmolive, Church & Dwight, Dr. Fresh Inc., Dentaid, Henkel AG & Co. KGaA, GlaxoSmithKline, Jordan AS, Johnson & Johnson, Lion Corp, Kao Corp, Oral-B Laboratories, Procter & Gamble, Unilever NV, and Sunstar.

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Ablation Technologies Market is Projected to Expand at a CAGR of 12.10% Between 2014 and 2020

    The global ablation technologies market is competitive in nature and is estimated to witness a high level of competition throughout the forecast period, states a new market research study by Transparency Market Research. Some of the leading players operating in the ablation technologies market across the globe are St. Jude Medical, Inc., Covidien PLC, Bioscience Webster Inc., Angiodynamics, Inc., Boston Scientific Corp, and Medtronic, Inc. These players are focusing on technological developments and innovations, which are estimated to accelerate the growth of the overall market in the next few years. In addition to this, the development of new product is another major factor, which is estimated to offer potential growth opportunities for the market players in the next few years.

    According to the market research report by Transparency Market Research, in 2013, the global market for ablation technologies was worth US$4.6 bn and is projected to reach a value of US$10.6 bn by the end of 2020. The market is likely to register a promising 12.10% CAGR between 2014 and 2020.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=294

    North America to Lead Global Ablation Technologies Market

    Among the key segments, North America is likely to account for a major share of the global ablation technologies market in the next few years. The rising contribution from Canada and the U.S. and the rising acceptance of novel technologies are some of the key factors that are estimated to accelerate the growth of this region throughout the forecast period. Furthermore, Asia Pacific is anticipated to register a high growth rate in the next few years, thanks to the rising population. The fast growth of this region can be attributed to the significant rise in the number of cases of chronic diseases, owing to the change in the lifestyle and food habits among people. Furthermore, the increasing number of patients, who are suffering from cancer, cardiovascular, and arthritis disorders.

    The global market for ablation technologies has been categorized on the basis of application into cardiovascular, pain management, gynecology, oncology, ophthalmology, urology, and others. Furthermore, on the basis of technology, the market has been categorized into radio frequency, electrical, microwave, light/laser, ultrasound, and cryotherapy. Among these, radio frequency segment is projected to account for a large share of the overall market in the next few years. The increasing number of applications in diverse segments is predicted to enhance the growth of the overall market in the next few years.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=294

    Advent of Next-generation Ablation Technologies to Encourage Market Growth

    The increasing incidence of cancer and the rising prevalence of cardiovascular diseases are some of the key factors that are predicted to encourage the growth of the global ablation technologies market in the next few years. In addition to this, the advent of next-generation ablation technology and products and the rising number of ablation procedure are estimated to accelerate the growth of the overall market in the next few years. On the flip side, the unfavorable regulatory scenario and the reprocessing and reuse of devices in several developing nations are projected to restrict the growth of the global ablation technologies market in the coming few years. Nonetheless, the increasing awareness related to the ablation procedures and the growth potential that are being offered by the developing nations are estimated to generate promising growth opportunities for the market players throughout the forecast period.

    This information is based on the findings of a research report published by Transparency Market Research (TMR), titled “Ablation Technologies Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, Ophthalmology; Technologies: Radiofrequency, Light/Laser, Electrical, Ultrasound, Microwave, Cryotherapy) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020.”

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Nebulizer Market is Expanding at US$937.7 mn by 2019

    A noticeable increase in the prevalence of chronic obstructive pulmonary disease (COPD) and asthma will lay the foundation for the steady growth of the global nebulizers market over the next three years, says Transparency Market Research in its latest report. The report is titled ‘Nebulizers Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.’ Another factor that will support the growth of the global nebulizers market is the adoption of government initiatives to reduce the prevalence of respiratory diseases. This trend has been brought about by the increasing healthcare burden of conditions such as asthma and COPD among patients in developing countries.

    The report states that nebulizers constituted a global market worth US$610.0 mn in 2012 and will reach a valuation of US$937.7 mn by 2019. The CAGR of the market is pegged at 6.5% between 2013 and 2019.

    A nebulizer is a medical device that converts liquids into a fine spray that can be easily inhaled by a patient to allow the drug to reach the respiratory tract. Nebulizers are most commonly used by asthma patients. Over the years, nebulizers have evolved in design and compactness to allow easier administration of drugs to patients. However, one major drawback with the design of nebulizers, which hasn’t been effectively addressed to date, is that a substantial amount of the drug is lost during delivery. TMR analysts say that this will restrain the growth of the global nebulizers market to some extent.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1436

    New opportunities are emerging in the Asia Pacific region for companies in the global nebulizers market. A staggeringly high number of people in regions such as Asia Pacific and Latin America suffer from COPD owing to the high pollution levels and other environmental factors here. Investments in these regions are thus expected to fetch good returns.

    The report conducts a segment-wise analysis of the global nebulizers market. To do this, TMR analysts have segmented the market on the basis of product type and geography. The types of nebulizers studied in the report include: ultrasonic nebulizer, pneumatic nebulizer, and mesh nebulizer. The findings of the report show that pneumatic nebulizers held the largest share in the global nebulizers market by product type in 2012. These nebulizers are easy to carry and use, making them convenient for patients of different ages. Of the two types of pneumatic nebulizers – breath-actuated and vented – the share of the former was the highest in 2012. The breath-actuated pneumatic nebulizers segment is also expected to expand at the highest CAGR over the forecast period.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2033

    Based on geography, the market is segmented into Europe, North America, Asia Pacific, and Rest of the World. Among these, the largest share in the nebulizers market was held by North America in 2012. Several government programs aimed at containing cystic fibrosis, COPD, and asthma have also benefited the market’s growth. Asia Pacific, being an emerging market, will exhibit the highest CAGR in the global nebulizers market through the report’s forecast period, which ranges from 2013 to 2019. This is attributable not only to the massive patient pool in need of effective medical devices here but also the fact that manufacturers are scaling up operations in countries such as South Korea, China, India, and Japan.

    Players that have a strong hold over the global nebulizers market are GF Health Products, Inc., Philips Healthcare, Omron Healthcare, and PARI Respiratory, Inc.

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Insulin Market is Expected to Demonstrate a CAGR of 6.1% till 2019

    Transparency Market Research has published a new report on the rapid medical diagnostics kits market that discusses its position in the global setting. The research report, titled “Global and China Insulin Market – Industry Analysis, Size, Share, Growth, 2013 – 2019,” offers an evaluation of the market in a political, economic, social, technological, legal, and environmental context. The report has also used a SWOT analysis and Porter’s five forces analysis to determine the factors governing the trajectory of this market in the near future.According to research report, the global and China insulin market stood at US$19.99 bn in 2012 and is expected to reach US$32.24 bn by 2019, registering a CAGR of 6.1% between 2013 and 2019. The positive growth in the valuation of the global and China insulin market will be mainly due to the increasing incidence of diabetes and rise in the research and development of insulin across the globe.

    The Chinese insulin industry is growing steadily as the type 1 diabetic population that needs insulin to manage the condition continues to grow. The proliferation of this market in China is also attributable to the improving medical infrastructure, changing lifestyles, drastic changes in dietary habits, and increasing preference for fast food.

    The global and China insulin market has been segmented on the basis of mode of action and source. Depending on the mode of action, the types of insulin in the market are long-acting, short-acting, rapid-acting, intermediate-acting, and premixed. The sources of insulin are differentiated into human and modern.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=259

    The long-acting insulin segment is expected to register a CAGR of 8.7% in the forecast period. This rise in the earnings of the long-acting insulin segment will be mainly be due its advantage of a smaller dosage offering better results as compared to the other types of insulin. The growth of this segment will also be supported by the lack of price restrictions for long-lasting insulin and a strong pipeline of products in the market. The success of long-acting insulin was closely followed by the rapid-acting insulin segment in 2012. In the same year, the premixed insulin segment held a share of more than 50% in the China insulin market.

    Some of the important companies profiled in the global rapid medical diagnostic kits market are Trinity Biotech Plc, Alere, Inc., Abbott Laboratories, Abaxis, Inc., Danaher Corporation, BioRad Laboratories, F. Hoffmann La Roche, Becton Dickinson & Company, MegaCor Diagnostik GmbH, MegaCor, and Zoetis, Inc. The research report also explains the competitive landscape in this market by evaluating the financial overview, business and marketing strategies, research and development activities, and investment outlook for the near future.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=259

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Hyaluronic Acid Products Market will Exhibit a CAGR of 9.20% From 2013-2019

    The global market for hyaluronic acid products is moderately competitive in nature and is projected to remain in the similar situation throughout the forecast period, states a new market research report by Transparency Market Research. Some of the leading players operating in the global market are Anika Therapeutics, Inc., Merz Aesthetics, and Allergan, Inc. These players are expected to witness a significant level of competition, thanks to the growing focus on research and development activities and innovations in this field. In addition to this, the increasing number of mergers and acquisitions is estimated to help the key players in expansion of product portfolio is predicted to enhance the overall growth of the market in the next few years. As per the study, a significant rise in the number of players is expected in the global hyaluronic acid products market.

    According to the market research report, the global market for hyaluronic acid products is expected to reach a value of US$9.85 bn by the end of 2019 and the market is likely to register a promising 9.20% CAGR between 2013 and 2019.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2033

    North America Hyaluronic Acid Products Market to lead in Near Future

    From a regional perspective, the global market for hyaluronic acid products has been categorized into the Middle East and Africa, North America, Latin America, Asia Pacific, and Europe. Among these, North America is projected to witness high growth in the next few years. The increasing demand for hyaluronic in North America can be attributed to the presence of a several leading players and the growing demand across diverse applications. Europe is anticipated to remain in the second position in terms of market share throughout the forecast period. Furthermore, Asia Pacific is likely to experience a significant growth in the coming years. The rising number of developments in the healthcare sector is one of the key factors estimated to accelerate the growth of the Asia Pacific market in the coming few years.

    Among the key application segments, the dermal fillings segment is likely to account for a large share of the market and is projected to remain in its leading position throughout the forecast period. The vesicoureteral reflux (VUR) and osteoarthritis segments are further anticipated to register a promising growth rate in the coming years. The rising demand for minimally invasive surgical procedures is one of the major factors projected to encourage the growth of the market in the near future. Moreover, the rising geriatric population in a large number of developing economies is anticipated to accelerate the growth of these two segments in the coming few years.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2033

    Rising Number of Applications to Accelerate Market Growth

    The global hyaluronic acid products market is expected to rise at a steady pace in the coming few years. The expansion of the product portfolio and the increasing number of applications are some of the key segments that are projected to accelerate the growth of the global hyaluronic acid products market in the next few years. Technological advancements and developments in this area are further estimated to enhance the market growth in the near future.

    On the other hand, the high cost of hyaluronic acid products is one of the major factors, which is predicted to restrict the growth of the global market in the next few years. Nevertheless, the rising number of mergers and acquisition, especially with local businesses is estimated to generate promising growth opportunities in the forecast period.

    This information is based on the findings of a research report published by Transparency Market Research (TMR), titled “Hyaluronic Acid Products Market (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Blood Flow Measurement Devices Market to Expand at a Healthy CAGR of 8.70% Between 2013 and 2019

    With a number of established players, the global blood flow measurement devices market is demonstrating a highly competitive landscape, states a new research report by Transparency Market Research (TMR). Transonic Systems Inc., Perimed AB, Moor Instruments Ltd., Medistim ASA, GF Health Products Inc., Deltex Medical, Cook Medical Inc., Compumedics Ltd., Atys Medical., and ArjoHuntleigh Inc. are some of the key vendors of blood flow measurement devices across the world. The focus of these players is predominantly on strengthening their position in the global market and for that they are increasingly involving into strategic alliances and mergers and acquisitions. The number of players in this market is also projected to surge in the near future, giving rise to the competition, states the research study.

    According to the research report, the global market for blood flow measurement devices stood at US$0.27 bn in 2012. Progressing at a CAGR of 8.70% during the period from 2013 to 2019, the market’s opportunity is anticipated to reach US$0.50 bn by the end of the forecast period. Ultrasonic doppler flowmeters, laser doppler flowmeters, and electromagnetic flowmeters are the main products available in this market. Among these, the demand for ultrasonic doppler flowmeters have been relatively higher and this trend is anticipated to remain so over the next few years, notes the market study.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1419

    Increasing Awareness Regarding Health and Fitness to Ensure North America’s Dominance

    In terms of the geography, North America has been leading the worldwide market for blood flow measurement devices, thanks to the high awareness level pertaining to health and fitness among consumers. Going forward, this regional market is likely to remain on the top in the years to come on account of the rising prevalence of circulatory diseases, such as peripheral vascular diseases. Among other regional markets, Europe and Asia Pacific are expected to register significant growth over the next few years due to the increasing acceptance of minimally invasive devices and the considerable rise in the disposable income, enabling consumers to spend on expensive treatments, reports the research study.

    High Prevalence of Peripheral Vascular Disorders to Boost Market

    The global market for blood flow measurement devices has been witnessing a significant rise in its valuation and is expected to remain observing high growth in the near future, thanks to the augmenting demand for these device, owing to the high prevalence of peripheral vascular disorders among people across the world. These devices find extensive application in the diagnosis of diabetic complications, arterial occlusions, and intracranial monitoring in stroke and brain injury. The increasing base of geriatrics population, extremely susceptible to a wide array of diseases, is also projected to support the growth of this market, considerably, states the research report.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1419

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


  • Medical Device Connectivity Market to Become Worth US$33.5 billion by the End of 2019

    According to the findings of a business intelligence study by Transparency Market Research (TMR), the medical device connectivity market is poised for strong excellence in the near future, while projecting the demand to expand at an exuberant CAGR of 37.8% during the forecast period of 2013 to 2019. Revenue-wise, the analyst of the report has estimated that the global medical device connectivity market will attain a value of US$33.5 billion by the end of 2019.

    While representing the sheer potential of the market for medical device connectivity, the analyst has also highlighted that most of the shares are consolidated among a handful of well-established players who have been catering to demands for since a long time. The report has identified GE Healthcare, Qualcomm Life, Philips, Cerner Corporation, and NantHealth as some of the most prominent players who are currently ahead of the curve. This players are also among the leaders in the medical device industry and their products are efficient at interconnecting within themselves and work on a globally recognized patterns. The report has been developed for targeted audiences such as hospitals and clinics, assisted-living facilities and home-settings, home care agencies, pharmacies, diagnostic and imaging centers, and healthcare bodies.

    Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1529

    Based on component, the report segments the medical device connectivity market into wireless hardware including Wi-Fi, Web Map Tile service (WMTS), and Bluetooth, wired hardware, and software. Among these, the wired hardware segment continues to provide for the most prominent chunk of demand. That being said, the wireless technology is primed to gain strong adoption in the MDC market owing to the flexibility and portability they offer. Among the wireless hardware segment, Wi-Fi has been identified as the key sub-segment.

    End user bifurcation of the market has been done into home healthcare, hospitals, and others. Presently, hospitals are provide for a landslide share of demand and are expected to hold onto their prominent position, although home healthcare segment is exhibiting stronger growth rate. Geographically, the developed country of the U.S., which has strong rate of adoption of new technologies, is expected to sustain North America are most lucrative region, followed by Europe. However, emerging economies of Japan, China, and Japan are expected to propel the demand from Asia Pacific at an above-average growth rate.

    Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1529

    Some of the key factors that will augment the demand in the global medical device connectivity market are: increasing penetration of EHRs, need for healthcare information exchange at a rapid rate, growing focus on the quality of care keeping patient safety at paramount, growing need to reduce healthcare costs, and increasing usage of medical devices for data analytics. On the other hand, high cost of deployment that is not welcome by small healthcare organizations, reluctance of medical practitioners to move beyond traditional methods, issues pertaining to integration between diverse devices, and data security concerns are obstructing the market from attaining its true potential. That being said, growing fields of telehealth and remote patient monitoring is anticipated to open new revenue avenues in this market.

    About us:

    Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

    Contact us:

    Transparency Market Research
    90 State Street,
    Suite 700,
    Albany
    NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free 866-552-3453
    Emailsales@transparencymarketresearch.com
    Websitehttp://www.transparencymarketresearch.com/


connect